378 related articles for article (PubMed ID: 28173818)
1. The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.
Brahma B; Putri RI; Karsono R; Andinata B; Gautama W; Sari L; Haryono SJ
World J Surg Oncol; 2017 Feb; 15(1):41. PubMed ID: 28173818
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Methylene Blue Test as Single Technique for Sentinel Lymph Node Biopsy in Early Stages Breast Cancer.
Hermansyah D; Rahayu Y; Azrah A; Pricilia G; Paramita D; Siregar ES; Sufida S; Simarmata A
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2765-2769. PubMed ID: 34582644
[TBL] [Abstract][Full Text] [Related]
3. The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy.
Brahma B; Putri RI; Sari L; Karsono R; Purwanto DJ; Gautama W; Andinata B; Haryono SJ
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31205300
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green detects sentinel lymph nodes in early breast cancer.
Liu J; Huang L; Wang N; Chen P
J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
[TBL] [Abstract][Full Text] [Related]
5. Observational study of blue dye-assisted four-node sampling for axillary staging in early breast cancer.
Narui K; Ishikawa T; Kito A; Shimizu D; Chishima T; Momiyama N; Ichikawa Y; Sasaki T; Nozawa A; Inayama Y; Shimada H; Endo I
Eur J Surg Oncol; 2010 Aug; 36(8):731-6. PubMed ID: 20609549
[TBL] [Abstract][Full Text] [Related]
6. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria.
Okoye CL; Ezeome ER
Niger J Clin Pract; 2022 Nov; 25(11):1805-1811. PubMed ID: 36412286
[TBL] [Abstract][Full Text] [Related]
7. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity and specificity of methylene blue dye as a single agent in sentinel lymph node biopsy for early breast cancer.
Aimir M; Nasser A; Rokayah J; Hardin M; Sohail M
Med J Malaysia; 2022 Sep; 77(5):552-557. PubMed ID: 36169065
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
13. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.
Varghese P; Mostafa A; Abdel-Rahman AT; Akberali S; Gattuso J; Canizales A; Wells CA; Carpenter R
Eur J Surg Oncol; 2007 Mar; 33(2):147-52. PubMed ID: 17081723
[TBL] [Abstract][Full Text] [Related]
14. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Alvarado MD; Mittendorf EA; Teshome M; Thompson AM; Bold RJ; Gittleman MA; Beitsch PD; Blair SL; Kivilaid K; Harmer QJ; Hunt KK
Ann Surg Oncol; 2019 Oct; 26(11):3510-3516. PubMed ID: 31297674
[TBL] [Abstract][Full Text] [Related]
15. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
[TBL] [Abstract][Full Text] [Related]
16. Blue-dye technique complements four-node sampling for early breast cancer.
Ishikawa T; Momiyama N; Hamaguchi Y; Tanabe M; Tomita S; Ichikawa Y; Nakatani Y; Sasaki T; Nozawa A; Inayama Y; Inui K; Shimada H
Eur J Surg Oncol; 2005 Dec; 31(10):1119-24. PubMed ID: 16005597
[TBL] [Abstract][Full Text] [Related]
17. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
[TBL] [Abstract][Full Text] [Related]
18. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
19. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
20. Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients.
Rauch P; Merlin JL; Leufflen L; Salleron J; Harlé A; Olivier P; Marchal F
Int J Surg; 2016 Sep; 33 Pt A():177-81. PubMed ID: 27504849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
